You are here: Home » News-CM » Companies » News
Business Standard

Lupin receives USFDA approval for Fluoxetine Tablets

Capital Market 

Lupin has received approval for its Tablets USP, 10 mg and 20 mg, from the Food and Drug Administration (FDA) to market a generic version of and Company's (Eli Lilly) Prozac Tablets, 10 mg and 20 mg.

Lupin's Tablets USP, 10 mg and 20 mg, is the generic version of Eli Lilly's Prozac Tablets, 10 mg and 20 mg.

It is indicated in the treatment of Major Depressive Disorder, bsessive Compulsive Disorder, and

Tablets, 10 mg and 20 mg, (RLD: Prozac) had annual sales of approximately USD 68.2 million in the US (IQVIA MAT December 2018).

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, April 16 2019. 14:16 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU